GSK1349572

A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults

GSK1349572 Hepatic Impairment Study

Drug Interaction Study Between GSK1349572 and Tipranavir/Ritonavir in Healthy Volunteers

A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects

GSK1349572 Drug Interaction Study With Efavirenz

Phase 1, Open Label, Two Arm, Fixed Sequence Study to Evaluate the Effect of Rifampin and Rifabutin on GSK1349572 Pharmacokinetics in Healthy Male and Female Volunteers

GSK1349572 Repeat Dose Escalation and Relative Bioavailability Study

GSK1349572 Drug Interaction Study With Fosamprenavir/Ritonavir

A Drug Interaction Study Evaluating Plasma GSK2248761 and GSK1349572 Pharmacokinetics in Healthy Adult Subjects.

Phase IIa Dose-ranging Study of GSK1349572 in HIV-1 Infected Adults

A Phase 1, Open Label, Placebo-Controlled Study to Evaluate the Effect of GSK1349572 on Iohexol and Para-Aminohippurate Clearance in Healthy Subjects

GSK1349572 Drug Interaction With Etravirine and Either Darunavir/Ritonavir or Lopinavir/Ritonavir

A Study to Investigate the Pharmacokinetics, Safety and Tolerability of GSK1349572 (Dolutegravir, DTG) in Healthy Japanese Subjects

GSK1349572 First Time in Human Study

GSK1349572 Drug Interaction Study With Protease Inhibitors

GSK1349572 Proton Pump Inhibitor Drug Interaction and Supratherapeutic Dose Study

GSK1349572 Drug Interaction Study With Atazanavir/Ritonavir and Atazanavir

A Study to Evaluate the Effect of Antacid and Multivitamin and Mineral Tablet on the Study Drug GSK1349572

GSK1349572 Drug Interaction Study With Etravirine